Clinical outcome of coronavirus disease 2019 in haemato-oncology patients

Br J Haematol. 2020 Jul;190(2):e64-e67. doi: 10.1111/bjh.16852. Epub 2020 Jun 10.

Authors

James A Aries^{1

2}, Jeffrey K Davies^{1

2}, Rebecca L Auer¹, Simon L Hallam¹, Silvia Montoto¹, Matthew Smith¹, Belen Sevillano¹, Vanessa Foggo¹, Bela Wrench^{1

2}, Krzysztof Zegocki³, Samir Agrawal¹, Rifca Le Dieu^{1

2}, Edward Truelove^{1

2}, Thomas Erblich^{1

2}, Shamzah Araf^{1

2}, Jessica Okosun^{1

2}, Heather Oakervee¹, Jamie D Cavenagh¹, John G Gribben^{1

2}, John C Riches^{1

2

4}

Affiliations

¹ Department of Haemato-oncology, Barts Health NHS Trust, St. Bartholomew's Hospital, London, UK.
² Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
³ Department of Haematology, Barts Health NHS Trust, Whipps Cross University Hospital, London, UK.
⁴ The Francis Crick Institute, London, UK.

No abstract available

Keywords: coronavirus; leukaemia; lymphomas; myeloma; virology.

Publication types

Historical Article
Letter

MeSH terms

Adult
Aged
Aged, 80 and over
Betacoronavirus / pathogenicity*
COVID-19
Coronavirus / pathogenicity*
Coronavirus Infections / etiology*
Hematologic Neoplasms / physiopathology*
History, 21st Century
Humans
Middle Aged
Pandemics
Pneumonia, Viral / etiology*
SARS-CoV-2